78 results match your criteria: "Research Institute-Hospital de la Santa Creu i Sant Pau[Affiliation]"
Curr Pharm Des
November 2019
Cardiovascular ICCC- Program, Research Institute Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain.
Dyslipidemia is widely accepted as one of the major risk factors in cardiovascular disease mainly due to its contribution in the pathogenesis of atherosclerosis in medium-sized and large arteries. However, it has become increasingly accepted that high-cholesterol levels can also adversely affect the microvasculature prior to the development of overt atherosclerosis. Moreover, hypercholesterolemia has shown, in preclinical animal models, to exert detrimental effects beyond the vascular tree leading to larger infarcts and adverse cardiac remodeling post-myocardial infarction.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
September 2018
Biomedical Research Institute Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona Spain.
Background: There is no agreement for the etiologic classification of patients with intracerebral hemorrhage (ICH). In a series of patients with ICH, we performed a randomized head-to-head comparison between the two recently proposed etiologic classification systems.
Methods: We evaluated patients registered in a prospective database of consecutive patients.
Adv Exp Med Biol
April 2010
Genetic and Research Institute Hospital de la Santa Creu i Sant Pau and CIBERER, Sant Antoni Ma. Claret 167, 08025, Barcelona, Spain.
Spinal muscular atrophy (SMA) is an autosomal recessive disorder that affects motor neurons. It is caused by mutations in the survival motor neuron gene 1 (SMN1). The SMN2 gene, which is the highly homologous SMN1 copy that is present in all patients, is unable to prevent the disease.
View Article and Find Full Text PDF